Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[idcc2006]

A petent by Mullan and Williams : Method of Treating Inflammatory Lung Disease. This is a use patent application, using anatabine for this disease.


Look at the applicant, inventors, and the date applied. Applicant is RCP development, not RCP.


Patent Application # US20160030407 A1
Date applied 9/25/2015
Inventors Michael Mullan, Daniel Paris, Jonnie R. Williams
Applicant RCP Development, Inc.